These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 3495304)
1. The effect of ABO blood group on the diagnosis of von Willebrand disease. Gill JC; Endres-Brooks J; Bauer PJ; Marks WJ; Montgomery RR Blood; 1987 Jun; 69(6):1691-5. PubMed ID: 3495304 [TBL] [Abstract][Full Text] [Related]
2. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681 [TBL] [Abstract][Full Text] [Related]
3. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). Tosetto A; Rodeghiero F; Castaman G; Bernardi M; Bertoncello K; Goodeve A; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I J Thromb Haemost; 2007 Apr; 5(4):715-21. PubMed ID: 17408405 [TBL] [Abstract][Full Text] [Related]
4. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms. Akin M; Balkan C; Karapinar DY; Kavakli K Clin Appl Thromb Hemost; 2012 Jun; 18(3):316-9. PubMed ID: 21949039 [TBL] [Abstract][Full Text] [Related]
5. Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors. Alharbi A; Hassan SB; Al-Momen AK; Al-Saleh K; Nasr R; Kohgear H; Owaidah T Blood Coagul Fibrinolysis; 2018 Mar; 29(2):211-215. PubMed ID: 29369083 [TBL] [Abstract][Full Text] [Related]
6. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease. de Romeuf C; Mazurier C Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Miller CH; Kelley L; Green D Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396 [TBL] [Abstract][Full Text] [Related]
8. Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. Nitu-Whalley IC; Lee CA; Griffioen A; Jenkins PV; Pasi KJ Br J Haematol; 2000 Feb; 108(2):259-64. PubMed ID: 10691852 [TBL] [Abstract][Full Text] [Related]
9. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen. Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703 [TBL] [Abstract][Full Text] [Related]
10. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741 [TBL] [Abstract][Full Text] [Related]
11. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level. Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190 [TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease. Favaloro EJ; Mohammed S Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192 [TBL] [Abstract][Full Text] [Related]
14. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays. Favaloro EJ; Mohammed S Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811 [TBL] [Abstract][Full Text] [Related]
15. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma. Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534 [TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353 [TBL] [Abstract][Full Text] [Related]